Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  130 نتائج ل ""EMPA""

فلترة النتائج

Subject : sodium-glucose transporter 2 inhibitors
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Jun 28; Vol. 23 (1), pp. 224. Date of Electronic Publication: 2024 Jun 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Empagliflozin and left atrial function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial.

Subjects: Glucosides*/Glucosides*/Glucosides*/therapeutic use ; Glucosides*/Glucosides*/Glucosides*/adverse effects ; Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/therapeutic use

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Aug 28; Vol. 23 (1), pp. 319. Date of Electronic Publication: 2024 Aug 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial.

  • Authors : Fitchett D; Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, ON, Canada.; Zinman B

Subjects: Glucosides*/Glucosides*/Glucosides*/therapeutic use ; Glucosides*/Glucosides*/Glucosides*/adverse effects ; Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/therapeutic use

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Jul 11; Vol. 23 (1), pp. 248. Date of Electronic Publication: 2024 Jul 11.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Use of diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA-REG OUTCOME trial.

  • Authors : Pellicori P; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.; Fitchett D

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/drug therapy ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: European journal of heart failure [Eur J Heart Fail] 2021 Jul; Vol. 23 (7), pp. 1085-1093. Date of Electronic Publication: 2021 Jun 28.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial.

  • Authors : Ferreira JP; Centre d'Investigations Cliniques Plurithématique Inserm 1433, CHRU de Nancy, Inserm U1116, FCRIN INI- CRCT, Université de Lorraine, Nancy, France. .; Verma S

Subjects: Atherosclerosis/Atherosclerosis/Atherosclerosis/*drug therapy ; Benzhydryl Compounds/Benzhydryl Compounds/Benzhydryl Compounds/*therapeutic use ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2020 Nov 26; Vol. 19 (1), pp. 200. Date of Electronic Publication: 2020 Nov 26.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial.

Subjects: Glycemic Control*/Glycemic Control*/Glycemic Control*/adverse effects ; Glycemic Control*/Glycemic Control*/Glycemic Control*/mortality; Benzhydryl Compounds/Benzhydryl Compounds/Benzhydryl Compounds/*therapeutic use

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2020 Oct 13; Vol. 19 (1), pp. 176. Date of Electronic Publication: 2020 Oct 13.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial

Subjects: Diabetes mellitus; Type 2; Myocardial infarction

  • Source: Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-7 (2024)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA-REG OUTCOME ® trial.

  • Authors : Kadowaki T; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Nangaku M

Subjects: Albuminuria/Albuminuria/Albuminuria/*drug therapy ; Benzhydryl Compounds/Benzhydryl Compounds/Benzhydryl Compounds/*therapeutic use ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*complications

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2019 May; Vol. 10 (3), pp. 760-770. Date of Electronic Publication: 2019 Jan 07.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Estimating the number of preventable cardiovascular disease events in the United States using the EMPA-REG OUTCOME trial results and National Health and Nutrition Examination Survey

Subjects: Clinical Research; Cardiovascular; Diabetes

  • Source: Diabetes and Vascular Disease Research. 17(4)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?

  • Authors : Sattar N; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Avenue, Glasgow, G12 8TA, UK. .; McLaren J

Subjects: Sodium-Glucose Transporter 2 Inhibitors*; Sodium-Glucose Transporter 2/Sodium-Glucose Transporter 2/Sodium-Glucose Transporter 2/*metabolism; Animals

  • Source: Diabetologia [Diabetologia] 2016 Jul; Vol. 59 (7), pp. 1333-1339. Date of Electronic Publication: 2016 Apr 25.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  130 نتائج ل ""EMPA""